Disposable Syringes Market Size is estimated to reach US$19.90Billion by 2033 with a CAGR of 5.9%, Dominate by North America 41% Market Revenue.

The global Disposable syringes market size reached US$ 11.24Billionin 2023 with a rise of US$11.86Billion in 2024 and is expected to reach US$19.90Billion by 2033, growing at a CAGR of 5.9%during the forecast period 2025-2033.

The Disposable Syringes Market growth is driven by rising vaccination programs, increasing chronic disease prevalence, stringent hygiene regulations, and growing demand for safe, single-use medical devices in emerging and developed regions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/disposable-syringes-market?prtk

United States: Key Industry Developments
✅ January 2026: BD launched BD Emerald safety-engineered disposable syringes with retractable needles, reducing needlestick injuries by 85% across 1,200 U.S. hospitals.
Features antimicrobial plunger seals meeting CDC guidelines for high-volume vaccination programs.

✅ November 2025: Cardinal Health introduced next-gen prefilled disposable syringes for insulin delivery, integrating NFC tracking for 99.9% dosage verification in home healthcare settings.
Supports 15M diabetic patients with tamper-evident packaging compliant with DSCSA serialization.

✅ September 2025: Terumo Medical expanded U.S. production of SurGuard safety syringes, boosting capacity 40% to supply 500M units annually amid flu/RSV vaccination surges.

Asia Pacific / Japan: Key Industry Developments
✅ January 2026: Terumo Japan released NanoPass microneedle disposable syringes reducing injection pain 70% for 2M rheumatoid arthritis patients under national health insurance.
Integrates with electronic medication history systems per MHLW digital transformation mandates.

✅ December 2025: Nipro Corporation launched eco-friendly biodegradable disposable syringes using PLA resin, approved for 80% single-use medical waste reduction in Tokyo hospitals.
Processes 300M units yearly aligning with Japan's Plastic Resource Circulation Act.

✅ October 2025: JMS Co. introduced Auto-Disable syringes with WHO-compliant retraction mechanism, distributed to 5,000 clinics preventing 95% reuse during national immunization campaigns.

Disposable syringes Market Recent M&A activities:-
→ In November 2025, Cardinal Health announced it anticipated completing the acquisition of Solaris Health, a healthcare foundation focused on specialized platforms. The transaction was valued at $1.9 billion and was intended to strengthen Cardinal Health's five operating segments, particularly its specialty and biopharmaceutical solutions.

→ In July 2025, Gerresheimer AG, a global partner to the pharmaceutical and biotech industries, ended discussions with private equity investors regarding a potential takeover offer for the company. While the takeover did not proceed, Gerresheimer continued to integrate its significant $867 million acquisition of Bormioli Pharma (completed in May 2024), which added a comprehensive portfolio of glass and plastic primary packaging, accessories, and dosing systems to its syringe offerings.

→ In April 2025, Gerresheimer AG entered into a strategic agreement with Injecto Group to supply complete silicone-oil- and PFAS-free syringe systems made of glass and cyclic olefin polymer (COP). This move was designed to provide safer containment solutions for sensitive biologics and ophthalmic applications.

Disposable syringes Market key Players:-

BD, B. Braun SE, Hindustan Syringes & Medical Devices, Gerresheimer AG, Nipro Corporation, and Cardinal Health.

Top 5 Key Players Analysis:-

BD (Becton, Dickinson and Company)
BD holds one of the largest global shares in disposable syringes (22 %), driven by its extensive product portfolio and innovation in safety‐engineered and auto‐disable syringes.

Hindustan Syringes & Medical Devices Ltd
HMD commands roughly a double‐digit share (12 %), strengthened by high production volumes and leadership in auto‐disable syringes for immunization programs.

Nipro Corporation
Nipro captures about 10 % of the market with strong manufacturing capacity and global OEM partnerships in precision‐molded disposable syringes.

B. Braun SE
B. Braun is a major player with significant international presence and diversified clinical consumables offerings, contributing notably to global syringe revenue.

Cardinal Health
Cardinal Health holds a meaningful position in the U.S. and global markets through its Monoject brand and broad distribution network, though with a smaller share than the top four.

Disposable syringes Market Top Technological Partnerships (2026 & 2025):-

BD & Ypsomed Expand Strategic Collaboration (2026)
Becton, Dickinson and Company (BD) and Ypsomed have strengthened their multi‐year partnership to co‐develop a 5.5 mL version of the BD NeopakTM XtraFlowTM glass prefillable syringe that integrates with Ypsomed's YpsoMate® 5.5 autoinjector platform - a move aimed at improving delivery of large‐volume and high‐viscosity biologic therapies.

Sharps Technology & European Distributor Qualification Collaboration
Sharps Technology, Inc. is advancing qualification and delivery of its SecureGardTM safety syringes in Europe by working closely with a major European medical supply distributor and healthcare networks - part of an ongoing commercialization and market adoption effort ahead of broader product rollout.

Sharps Technology & Nephron Syringe Sales Agreement
Sharps signed a 5‐year, $200 million syringe sales agreement with Nephron Pharmaceuticals, tied to acquisition of specialty syringe assets and intended to begin production of copolymer prefillable syringes in the U.S. with initial shipments expected in Q2 2025.

BD Showcases Advanced Delivery Systems & Partnership Intent at Pharmapack 2025
At Pharmapack 2025, BD highlighted a portfolio of advanced drug delivery technologies, including disposable autoinjectors and wearable injectors, and reiterated ongoing partnerships with pharmaceutical and biotech firms to innovate treatments (especially for biologics, vaccines, and home‐based therapies).

BD & Ten23 Health RFID Traceability Collaboration
BD partnered with Ten23 Health to pilot an RFID‐based traceability solution for prefillable syringes, enhancing manufacturing efficiency and enabling precise tracking of individual units across production and supply chains.

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=disposable-syringes-market?prtk

Disposable syringes Market Drivers :-
The global healthcare landscape is shifting toward injectable medications for chronic and complex conditions. With biologics, insulin, and therapeutic injections becoming standard (e.g., diabetes, rheumatoid arthritis), clinicians increasingly rely on single‐use syringes to ensure sterile, accurate drug delivery. According to WHO data, roughly 16 billion injections are administered worldwide annually, with nearly 90 % used for curative care underscoring the essential role of disposable syringes in routine healthcare delivery.

From pandemic responses to routine immunization programs, national and global initiatives are driving high‐volume syringe procurement. Expanded immunization efforts often centrally tendered in emerging economies generate consistent, large‐scale demand for safe, single‐use devices. This trend not only increases total units consumed but also anchors syringes as indispensable in public health strategies against diseases like hepatitis, measles, and COVID‐19.

Needlestick injuries and infection control concerns have accelerated the shift from basic syringes to safety‐engineered designs (e.g., auto‐disable, retractable mechanisms). Regulatory push from bodies like FDA, OSHA, and WHO has made safety features standard in many hospitals, boosting adoption rates of advanced products that can reduce injury risk by up to 88 % compared to conventional models. This trend enhances both patient and healthcare worker safety while commanding premium pricing and growth rates within the broader market.

Global rises in chronic conditions including diabetes, cancer, and cardiovascular disease create a recurring need for injectable treatments and diagnostic draws. Detailed regional analyses show therapeutic injections accounting for around 60-75 % of syringe applications, reflecting consistent, high‐frequency usage patterns that strengthen long‐term market expansion.

Disposable syringes Market Regional Insights:-

1. North America
Market Share: 41% of the global disposable syringes market, the largest regional share globally driven by advanced healthcare infrastructure, strong vaccination programs, and safety‐focused regulations.
Insight: The U.S. leads with high usage for chronic disease injections and preventive care; Canada and Mexico contribute through growing outpatient and immunization demand.

2. Europe
Market Share: 29% regional share supported by strict safety guidelines and high adoption of single‐use devices across major markets like Germany, UK, France, and Italy.
Insight: Regulatory focus on injection safety and extensive healthcare services sustain consistent syringe usage across hospitals and clinics.

3. Asia‐Pacific
Market Share: 31% with rapid growth due to expanding healthcare access, large population base, and extensive vaccination programs in China and India.
Insight: Fastest‐growing region driven by urbanization, public‐sector immunization campaigns, and rising chronic disease prevalence.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/disposable-syringes-market?prtk

Disposable syringes Market Market Segmentation
By Product: The disposable syringes market is segmented based on product type, including conventional disposable syringes, safety disposable syringes, prefilled syringes, oral syringes, and specialized syringes. Each type caters to different medical needs, with safety and prefilled syringes gaining popularity due to reduced contamination risk and enhanced convenience.

By Application: Based on application, the market is divided into therapeutic injections and immunization injections. Therapeutic injections cover routine medical treatments, while immunization injections focus on vaccines, highlighting the critical role of syringes in preventive healthcare and disease control.

By End User: The end-user segmentation includes hospitals, diagnostic laboratories, blood banks, the pharmaceutical industry, vaccination centers, and veterinary purposes. This ensures that disposable syringes are tailored to diverse healthcare settings, meeting both human and animal medical requirements efficiently.

This research report delivers actionable insights, data-driven analysis, and future-ready perspectives that enable informed decision-making, reduce market risks, and uncover growth opportunities across the industry

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.